The cell and molecular biology of glaucoma: Axonopathy and the brain

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 5, 2012, Pages 2482-2484

  Calkins, David J ^a,b   Horne, Philip J ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE;

AGE; APOPTOSIS; ARTICLE; CELL COMPARTMENTALIZATION; CELL LOSS; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NERVE CELL NETWORK; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NEUROPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PRIORITY JOURNAL; RETINA GANGLION CELL;

AGE FACTORS; ANIMALS; AXONS; GLAUCOMA; HUMANS; NEURODEGENERATIVE DISEASES; OPTIC NERVE; RETINAL GANGLION CELLS;

EID: 84860635968     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9483i     Document Type: Article

References (15)

1. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, and the Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48-56.
2. Whitmore AV, Libby RT, John SW. Glaucoma: thinking in new ways: a role for autonomous axonal self-destruction and other compartmentalised processes? Prog Retin Eye Res. 2005;24(6): 639-662.
3. Qu J, Wang D, Grosskreutz CL. Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res. 2010;91(1):48-53.
4. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41(3):741-748.
5. Buckingham BP, Inman DM, Lambert W, et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci. 2008;28(11):2735-2744.
6. Libby RT, Li Y, Savinova OV, et al. Susceptibility to neurodegen-eration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005;1(1):17-26.
7. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurode-generation. Proc Natl Acad Sci U S A. 2010;107(11):5196-5201.
8. Crish SD, Calkins DJ. Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience. 2011;:1-11.
9. Lambert WS, Ruiz L, Crish SD, Wheeler LA, Calkins DJ. Brimoni-dine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol Neurodegener. 2011;6(1):4.
10. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006;7:66.
11. Gupta N, Ang LC, Noël de Tilly L, Bidaisee L, Yücel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol. 2006;90:674-678.
12. Burgoyne CF. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res. 2011; 93(2):120-132.
13. Chan KC, Li J, Kau P, et al. In vivo retinotopic mapping of superior colliculus using manganese-enhanced magnetic resonance imaging. Neuroimage. 2011;54(1):389-395.
14. Chan KC, Fu QL, Hui ES, So KF, Wu EX. Evaluation of the retina and optic nerve in a rat model of chronic glaucoma using manganese-enhanced magnetic resonance imaging. Neuroimage. 2008; 40:1166-1174.
15. Calkins DJ, Horner PJ, Roberts R, Gradianu M, Berkowitz BA. Manganese-enhanced MRI of the DBA/2J mouse model of hereditary glaucoma. Invest Ophthalmol Vis Sci. 2008;49(11):5083-5088.